Annoucement for Abstracts Selection
Congratulations to the authors/submitters of 48 selected abstracts who will be invited to the 6th HTAsiaLink Annual Conference “Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage” to be held during 17-20 April 2017 in Hanoi, Vietnam. Please see the list of 54 selected abstracts below.
We would like to take this opportunity to express our sincere thanks to all submitters for your contribution to the HTAsiaLink Annual Conference 2017.
1. Economic Evaluation (26)
|EE0101||Cost-utility analysis of an oral precancer screening program in Thailand||Chutima Kumdee||Thailand|
|EE0202||Cost-effectiveness of Trastuzumab in treatment for early-stage breast cancer patients with HER2+ in Vietnam||Nguyen Quynh Anh||Vietnam|
|EE0203||COST-EFFECTIVENESS ANALYSIS OF EARLY VERSUS LATE ANTIRETROVIRAL THERAPY TREATMENT FOR HIV/AIDS OUTPATIENTS IN THAI NGUYEN PROVINCE, VIETNAM||KQ Tuan||Vietnam|
|EE0204||Cost-effectiveness analysis of screening for and managing identified hypertension for cardiovascular disease prevention in Vietnam||Phuong Lan||Vietnam|
|EE0205||Cost and cost-effectiveness of liraglutide for treatment of diabetes mellitus type II- A systematic review||Kieu Thi Tuyet Mai||Vietnam|
|EE0206||Development of relative value units of medical services: a study on unit cost analysis in Vietnam.||Trung Quang Vo||Vietnam|
|EE0207||Cost-effectiveness of treating osteoporosis with alendronate and zoledronic acid in Vietnamese women||Van H. N. Pham||Vietnam|
|EE0308||Economic evaluation of policy options for dialysis in end-stage renal disease patients under the Universal Health Coverage in Indonesia||Afiatin||Indonesia|
|EE0409||Costs and benefits of intensive inpatient rehabilitation treatments on patients after stroke in Korea||Youshin Suh||Korea|
|EE0510||EQ-5D-5L vs EQ-5D-3L: comparing psychometric properties in Malaysians||Annushiah Vasan Thakumar||Malaysia|
|EE0511||Potential impact of closed-loop artificial pancreas for patients with type 1 diabetes mellitus||Izzuna MMG||Malaysia|
|EE0515||Estimating the utility value of hypoglycaemia using the time trade-off (TTO) and visual analogue scale (VAS) methods||Chin Hui Ng||Malaysia|
|EE0519||Comparison of Morisky Medication Adherence Scale, Medication Possession Ratio and Percentage of On-Time Refillin measuring adherence among hypertensive patients||Bee Ying Tan||Malaysia|
|EE0520||How much does an asthma-related event cost in a Malaysian suburban hospital?||Yee Vern Yong||Malaysia|
|EE0721||Progression-free survival outcomes of erlotinib, gefitinib and afatinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer: a network meta-analysis||Gloria Wan Hui Tan||Singapore|
|EE0722||Cost analysis of MRI-Ultrasound Fusion Software for prostate biopsies||Goh Geraldine||Singapore|
|EE0723||Cost-effectiveness analysis of sodium-glucose co-transporter 2 (SGLT2) inhibitors in type 2 diabetes mellitus (T2DM)||Ivan Kan||Singapore|
|EE0724||Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation||Ling Eng Tan||Singapore|
|EE0725||Cost-utility analysis using EQ-5D utility values: does the choice of value set matter?||\||Singapore|
|EE0726||Extrapolation of survival data to inform cost-effectiveness modelling||Mohamed Ismail Abdul Aziz||Singapore|
|EE0728||Appropriate care of pre-diabetes in Singapore||Yunjoo Karris Jeon||Singapore|
|EE0829||Providing baseline quality of life (QOL) estimates for Health Technology Assessment Research: QOL among patients with myocardial infarctions in Sri Lanka||Mahesh PKB||Sri Lanka|
|EE0931||Economic evaluation of lung cancer screening with low-dose computerized tomography for smoking and non-smoking groups||Chao-Ming Chang||Taiwan|
|EE1133||CEA of China Child Survival Strategy||Yingpeng Qiu||China|
|EE0518||HPV urine test for cervical cancer screening||Syful Azlie MF||Malaysia|
|EE0727||Cost-effectiveness analysis of afatinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer||Ping-tee Tan||Singapore|
2. Health System Research (28)
|HR0101||Designing the Free Drugs List (FDL) in Nepal: a balancing act between technical strengths and policy processes||Alia Cynthia Gonzales Luz||Thailand|
|HR0103||Evaluation of the prevention and control of Down’s syndrome pilot project||Natthida Malathong||Thailand|
|HR0104||A review of international experiences regulating off-label use of medicines||Nattiya Kapol||Thailand|
|HR0105||Measuring health-related quality of life in systemic juvenile idiopathic arthritis patients||Nitichen Kittiratchakool||Thailand|
|HR0107||The Need, Demand and Supply for Health Technology Assessment in India||Saudamini Dabak||Thailand|
|HR0108||How Does Universal Health Coverage Impact Out-of-Pocket Expenditure on Health? Preliminary Results from Analysis of Household Survey Data in Thailand||Suppawat Permpolsuk||Thailand|
|HR0109||From Delivery to Data: An assessment of the availability and reliability of data in a routine database to inform the feasibility of performance indicators||Suthasinee Kumlaung||Thailand|
|HR0212||Assessing the appropriate medical indications for the use of cancer drugs in the health benefits package in Vietnam||Hien Pham Van||Vietnam|
|HR0213||Use of evidence to support the development of health benefits package in Vietnam: a case study of antibiotics||Toi Phung Lam||Vietnam|
|HR0214||Alarming consumption of non-essential drugs in a district hospital in Vietnam||Nguyen Vinh Nam||Vietnam|
|HR0316||REVIEW OF LAWS, REGULATIONS AND USES OF OFF-LABEL DRUGS IN INDONESIA||Prastuti Soewondo||Indonesia|
|HR0519||Rare disease management in Malaysia||Azuwana Supian||Malaysia|
|HR0520||Access to cancer drugs: Are we meeting the needs of Malaysian?||Haarathi Chandriah||Malaysia|
|HR0521||Potential efficacy and safety of wearable dialysis device for end stage renal disease||Maria J,||Malaysia|
|HR0522||Inter-atrial shunt device (IASD) for heart failure with preserved ejection fraction (HFPEF) – potential efficacy and safety||Maria J,||Malaysia|
|HR0523||Approval of oncology drugs into Ministry of Health Medicines Formulary (MOHMF) in Malaysia||Nazatul Idrus||Malaysia|
|HR0524||Economic Burden of Heart Failure In Hospital Queen Elizabeth II, Kota Kinabalu, Sabah||Yui Ping Tan||Malaysia|
|HR0525||FEMTOSECOND LASER ASSISTED CATARACT SURGERY: HOW SAFE AND EFFECTIVE?||Roza Sarimin||Malaysia|
|HR0627||Towards legitimate priority setting in health: a checklist for being accountable to adversely affected stakeholders.||Maarten P. Jansen||The Netherlands|
|HR0728||Health technology assessment and health policy-making in Singapore – current status, challenges and potential||Fiona Pearce||Singapore|
|HR0829||Multi-criteria decision analysis in the path to universal health coverage in Sri Lanka||Perera S K||Sri Lanka|
|HR0830||Stakeholder perception on institutionalizing health technology assessment in Sri Lanka||Perera S K||Sri Lanka|
|HR0931||Use Interrupted Time Series Analysis in Evaluating the Central Line Care Quality Improvement Project in Taiwan||Tzu-I Chen||Taiwan|
|HR1133||Analyzing the multiple factors influencing the medical professionals’ cognition of the intergrated care model in China||Rui Zhao||China|
|HR0106||Developing the National List of Essential Medicines Using Economic Evaluation and Budget Impact Evidence: Lessons from Thailand||Pattara Leelahavarong||Thailand|
|HR0110||A study of feasibility of investing and access to spirometry service in community hospitals||Thanaporn Bussabawalai||Thailand|
|HR0111||Challenges of school health services implementation in the context of Thai local authority’s primary schools||Wilailak Saengsri||Thailand|
|HR0526||Health Technology ReAssessment methods in Malaysia||Yong YV||Malaysia|
Call for Abstracts - Showcase your research at the 6th HTAsiaLink Annual Conference
We are calling for abstracts to the 6th HTAsiaLink Annual Conference which will take place in Hanoi from 17 to 20 April, 2017. Pre-conference workshops will be held on the morning of April 17.
The 2017 Conference will be hosted by the Health Strategy and Policy Institute (HSPI) – Ministry of Health of Vietnam. HSPI serves as a focal point in health technology assessment development in Vietnam and facilitates exchange of knowledge and will feature plenary lectures by key international experts and regional thought leaders.
In the context of double burden of chronic and infectious disease among aging populations and the rapid emergence of new, expensive drugs and advanced medical technologies with the growing public expectations for accessing such treatments at an affordable level, and with the goal to achieve universal health coverage (UHC) the Asia-Pacific countries face the pressure of delivering high quality healthcare with constrained public funds. These conditions raise the interest in using evidences from health technology assessment to inform coverage decisions.
This year’s theme focuses on “Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage”. Authors of accepted abstracts will present their work to an experienced panel of commentators during the Conference. There will be two tracks of oral abstract presentations – Economic Evaluations and Health System Research. Economic Evaluations related to health benefit package for UHC are more preferred. Prizes will be awarded to the best presentations in each track.
Structure of abstract:
- Abstract to be written in English only
- The total length of the abstract must not exceed 300 words
- The body of the abstract will be structured with the following subtitles:
- Font Size: 11
- Font: Arial
- Allowed file type: Microsoft Word Format
Please refer to the abstract template.
Abstract deadline: 10 January 2017
Announcement for accepted abstracts: 10 February 2017
Please send your abstract to email@example.com by 10 January 2017.
We look forward to welcoming you to the 6th HTAsiaLink Annual Conference in Vietnam!
Template : [HTAsiaLink2017] Abstract Template
WHAT IS HTAsia Link 2017 Annual Conference
The HTAsiaLink is a collaborative regional network consisting of more than 20 agencies in 15 different countries in Asia and Pacific region that performs health technology assessment (HTA). The network focuses on facilitating HTA research by accelerating information and resources sharing and to develop an efficient methodology for HTA in the region. HTAsiaLink has been organising annual conferences since 2012 and member countries take turns to organise and host the conference. The 6th annual conference will be organized in Vietnam and hosted by Health Strategy and Policy Institute (HSPI). HSPI is an autonomous institution under the overall Minisrtry of Health umbrella, playing role in doing research to provide evidences and advice for policy making on health policies and working as focal point in HTA development in the country.
The theme of this year conference is “Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage”.
For more information about HTAsialink, please visit website: http://www.htasialink.org